• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,237.99 -160.73
( -0.21%)
Global Indices
Nasdaq
49,543.85 -540.61
(-1.08%)
Dow Jones
7,428.26 -93.98
(-1.25%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,172.40 -200.53
(-1.93%)
Forex
USD-INR
95.71 0.07
(0.07%)
EUR-INR
111.93 -0.13
(-0.12%)
GBP-INR
129.01 -0.31
(-0.24%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Pfizer standalone net profit declines 39.62% in the March 2026 quarter
May 13,2026
Net profit of Pfizer declined 39.62% to Rs 199.82 crore in the quarter ended March 2026 as against Rs 330.94 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 629.23 crore in the quarter ended March 2026 as against Rs 591.91 crore during the previous quarter ended March 2025.

For the full year,net profit declined 5.88% to Rs 722.43 crore in the year ended March 2026 as against Rs 767.60 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 2519.65 crore in the year ended March 2026 as against Rs 2281.35 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales629.23591.91 6 2519.652281.35 10
OPM %37.5038.43 -35.8832.45 -
PBDT274.56269.39 2 1082.56904.07 20
PBT259.78252.99 3 1024.83843.28 22
NP199.82330.94 -40 722.43767.60 -6